METTL3 and hepatocellular carcinoma: The high expression of methyltransferase-like proteins (METTL)3 in hepatocellular carcinoma (HCC) induces degradation of the tumor suppressor gene suppressor of cytokine signaling 2 (SOCS2) via m6A modification and is associated with poor prognosis [8].